A Systematic Review and Meta-Analysis of Hypoglycemia and Cardiovascular Events: A comparison of glyburide with other secretagogues and with insulin
about
Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic reviewSulphonylurea monotherapy for patients with type 2 diabetes mellitusSulphonylurea monotherapy for patients with type 2 diabetes mellitusNon-incretin insulin secretagogues for patients with type 2 diabetes mellitusMedical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of DiabetesThe Association between Sulfonylurea Use and All-Cause and Cardiovascular Mortality: A Meta-Analysis with Trial Sequential Analysis of Randomized Clinical TrialsPancreatic regulation of glucose homeostasisDrug-related risk of severe hypoglycaemia in observational studies: a systematic review and meta-analysisWhat's next after metformin? focus on sulphonylurea: add-on or combination therapyHypoglycemia in Patients with Diabetes and Renal DiseaseUpdate on the treatment of type 2 diabetes mellitusPreventing Unnecessary Costs of Drug-Induced Hypoglycemia in Older Adults with Type 2 Diabetes in the United States and CanadaLack of Evidence to Guide Deprescribing of Antihyperglycemics: A Systematic Review.Cardiovascular events and all-cause mortality associated with sulphonylureas compared with other antihyperglycaemic drugs: A Bayesian meta-analysis of survival data.Standard and Novel Treatment Options for Metabolic Syndrome and Diabetes MellitusKCNJ11, ABCC8 and TCF7L2 polymorphisms and the response to sulfonylurea treatment in patients with type 2 diabetes: a bioinformatics assessment.The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis.Managing medications in clinically complex elders: "There's got to be a happy medium".Cardiovascular impact of drugs used in the treatment of diabetesDiabetes: glycaemic control in type 2 (drug treatments).Potentially inappropriate prescribing of primarily renally cleared medications for older veterans affairs nursing home patientsA real world comparison of sulfonylurea and insulin vs. incretin-based treatments in patients not controlled on prior metformin monotherapy.Antidiabetic pharmacotherapy and anamnestic hypoglycemia in a large cohort of type 2 diabetic patients--an analysis of the DiaRegis registryCounterregulatory responses to hypoglycemia differ between glimepiride and glyburide in non diabetic individuals.A consumer-targeted, pharmacist-led, educational intervention to reduce inappropriate medication use in community older adults (D-PRESCRIBE trial): study protocol for a cluster randomized controlled trial"Symptom-based insulin adjustment for glucose normalization" (SIGN) algorithm: a pilot studyChanges in Type 2 Diabetes Mellitus Patients in German Primary Care Prior to (2006) and After (2010, 2014) Launch of New DrugsEffects of sitagliptin beyond glycemic control: focus on quality of life.Estimating the effect of sulfonylurea on HbA1c in diabetes: a systematic review and meta-analysis.Risk of hypoglycemia following intensification of metformin treatment with insulin versus sulfonylurea.Consensus guidelines for oral dosing of primarily renally cleared medications in older adults.Hypoglycemia: The neglected complicationSelf-monitoring of blood glucose in diabetes mellitus: arguments for an individualized approach.The intersection of safety and adherence: new incretin-based therapies in patients with type 2 diabetes mellitus.PURLs: Need an add-on to metformin? Consider this.Add-on therapies to metformin for type 2 diabetes.Medically minimising the impact of hypoglycaemia in type 2 diabetes: a review.Drug-induced hypoglycaemia in type 2 diabetes.Individualized treatment of type 2 diabetes mellitus using noninsulin agents: clinical considerations for the primary care physician.Impact of the sitagliptin alert on prescription of oral antihyperglycemic drugs in Japan.
P2860
Q22242077-E0400B6F-0342-4D18-951D-F4F9ECBEC843Q24186660-929786BB-B3D9-4949-94F3-85BD344F260FQ24197884-87D894E0-7472-40FD-BCA6-563EE02E24C7Q24234574-3ACAF209-324F-40E9-9FD2-ECE109A3D97AQ24642503-7EF38AC9-89DB-4836-8C08-3519167F40ABQ26748870-FA3CC4DE-7B75-42BC-8CB6-713E4DC838D3Q26766485-6C57E55C-0EB7-4AFE-BA12-911D902DDA80Q26784192-1A20F242-0D02-45C5-AD78-BA3861602ED5Q26786524-56B6F37E-6700-4254-A123-60EC053AC370Q26799515-9E7B7FEA-7FF8-4A57-98C2-5D792A5D6CA6Q28073342-D29A58BE-5446-4041-AC3C-DBD6341BE1C7Q28554260-AE8C7695-2267-4553-8E5B-96C210678781Q30240040-0A878114-FE66-4F62-9735-AB7066CF8348Q31143283-EAF7AE72-836E-4147-B4B6-BC085173811AQ33618721-C31E74D8-D501-401C-86CD-C145BA5CE4DFQ33771570-E509ECFC-194B-47BB-84B5-54047894CC01Q33873053-DE404D60-6574-409B-8EC5-B2F641F16972Q34311242-9A18DD63-5361-42C1-864C-678E65226D2EQ34383575-5EB88CCD-724A-4111-AE29-39668F46603CQ34829290-35E3A284-2CB9-44EA-A044-7C10BAE0DC4FQ35007528-C02B0A03-83D4-48BF-A063-1884F50F03A3Q35073584-D0E0D32D-F37E-4BB1-8C8D-BF02D8D45B5CQ35183113-48652813-20EE-4654-8EFE-8A642955C93CQ35533439-233FFCCB-8859-4E29-802C-8A5167A862A5Q35881312-6A8BFA0D-E375-4EE8-89BE-2B27FA378E6FQ36463579-0A593521-BF01-4EF4-970B-44E9A58567ECQ36638899-F5314B2F-269E-4554-A75B-BABEB2C32E66Q36710708-6511C37C-6237-4C97-9459-9158E7EC0E1FQ36755942-E44F36FC-45F3-4A20-9E64-BF4C402F2852Q36757698-798609F3-2DCD-42BE-9B37-CA0F45A86F5DQ37093020-C2EA3EC8-4C27-4857-9C84-FE6048556F6BQ37201653-AA5074C2-76F1-44A6-B4C4-1E7D812D94A0Q37405143-852479EC-3A1A-42F8-8E41-A4EE2F44E04BQ37641333-0266A29D-462C-43D6-BBC1-57C68D2838A2Q37670657-7B942096-D14C-4B88-A879-5BB729444FC1Q37818234-A28AF5CA-41F1-4091-AD08-5316A3F41DEFQ37888723-E7887C3E-66E9-4260-97B2-9FEF2F049655Q38018110-E6AA0E99-1839-43FF-9EFC-F5FFB5020852Q38036773-05FAF219-F1C1-4310-BB10-6274C20E24D6Q38039957-59EA93BC-7E00-4495-AB8C-665A73064C0A
P2860
A Systematic Review and Meta-Analysis of Hypoglycemia and Cardiovascular Events: A comparison of glyburide with other secretagogues and with insulin
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
A Systematic Review and Meta-A ...... secretagogues and with insulin
@ast
A Systematic Review and Meta-A ...... secretagogues and with insulin
@en
type
label
A Systematic Review and Meta-A ...... secretagogues and with insulin
@ast
A Systematic Review and Meta-A ...... secretagogues and with insulin
@en
prefLabel
A Systematic Review and Meta-A ...... secretagogues and with insulin
@ast
A Systematic Review and Meta-A ...... secretagogues and with insulin
@en
P2093
P31
P921
P3181
P356
P1433
P1476
A Systematic Review and Meta-A ...... secretagogues and with insulin
@en
P2093
A. S. Gangji
C. H. Goldsmith
C. M. Clase
H. C. Gerstein
T. Cukierman
P304
P3181
P356
10.2337/DC06-1789
P407
P577
2007-01-26T00:00:00Z